Issues To Watch In Fed. Circ. Hep C Drug Patent Case

By Robert Scheffel and Matthew Dowd
June 7, 2019, 3:10 PM EDT

In a fully briefed appeal scheduled for oral argument on July 9, 2019, the U.S. Court of Appeals for the Federal Circuit will again address the issue of enablement but in...

Already a subscriber? Click here to view full article